Cervical cancer screening is still lower than 10 per cent despite being the most common cancer after breast cancer in the country. Updated Tue, August 2nd 2016 at 15:19 GMT +3NAIROBI, KENYA: Women can now privately collect their own samples to be screened for cervical cancer using a new technology. The new screening DNA-based technology, dubbed Cobas, tests for the presence of a sexually transmitted virus which causes almost all cases of cervical cancer. Pathologists Lancets Kenya Managing Director Ahmed Kalebi noted that the test gives a clear indication of a woman's risk of developing that type of cancer, thereby enhancing efforts to effectively combat the disease. Kalebi added that the initiative introduces new technologies that make the screening more woman friendly, private, accurate and efficient before.

Source: Standard Digital August 02, 2016 12:33 UTC